Moderna, Inc.
MRNA
$26.26
-$0.46-1.72%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -971.00M | -1.12B | 13.00M | -1.28B | -1.18B |
| Total Depreciation and Amortization | 39.00M | 60.00M | 52.00M | 41.00M | 36.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 106.00M | 148.00M | 98.00M | 110.00M | 90.00M |
| Change in Net Operating Assets | -211.00M | 1.74B | -1.73B | -146.00M | 60.00M |
| Cash from Operations | -1.04B | 825.00M | -1.57B | -1.27B | -989.00M |
| Capital Expenditure | -117.00M | -522.00M | -151.00M | -182.00M | -196.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 847.00M | -17.00M | 872.00M | 1.83B | 314.00M |
| Cash from Investing | 730.00M | -539.00M | 721.00M | 1.65B | 118.00M |
| Total Debt Issued | 2.00M | -4.00M | 3.00M | 1.00M | -- |
| Total Debt Repaid | -- | -10.00M | -- | 1.00M | -1.00M |
| Issuance of Common Stock | 3.00M | 11.00M | 8.00M | 32.00M | 15.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.00M | -- | -- | -- | -- |
| Cash from Financing | 4.00M | -3.00M | 11.00M | 34.00M | 14.00M |
| Foreign Exchange rate Adjustments | -- | -1.00M | 1.00M | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -303.00M | 282.00M | -833.00M | 409.00M | -857.00M |